China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a report released on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

Shares of NYSE:CPHI opened at $0.32 on Monday. The business has a fifty day simple moving average of $0.35 and a 200 day simple moving average of $0.45. China Pharma has a 12-month low of $0.27 and a 12-month high of $2.18. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Recommended Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.